FDA Drug Recalls

Recalls / Class II

Class IID-0065-2023

Product

PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.

Affected lot / code info
Lots: NE1062A, NE1062B Exp. 12/02/2022; NE1065A, NE1065B Exp. 12/13/2022; NE2011A, NE2011B Exp. 03/15/2022.

Why it was recalled

CGMP Deviations: Potential for cross contamination due to product carry over.

Recalling firm

Firm
Nephron Sterile Compounding Center LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4500 12th Street Ext, N/A, West Columbia, South Carolina 29172-3025

Distribution

Quantity
56,220 vials
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-11-10
FDA classified
2022-11-17
Posted by FDA
2022-11-23
Terminated
2024-09-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0065-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.